Overview

An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

Status:
Completed
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the abuse potential of gabapentin enacarbil in healthy adult, non-dependent, recreational drug users.
Phase:
Phase 4
Details
Lead Sponsor:
Azurity Pharmaceuticals
Treatments:
Alprazolam
Gabapentin